Royalty Pharma declares fourth quarter 2026 dividend
NEW YORK, Oct. 16, 2026 (GLOBE NEWSWIRE) -- The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the fourth quarter of 2026 of $0.235 per Class A ordinary share.
Covered in this story
Call it yourself
No calls on $RPRX yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Royalty Pharma →Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.